RECOMBINANT HUMAN MACROPHAGE COLONY-STIMULATING FACTOR AUGMENTS PULMONARY HOST DEFENCES AGAINST ASPERGILLUS FUMIGATUS

This publication has 44 references indexed in Scilit:

• Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens
  Cytokine, 1996
• In vivo and in vitro effects of macrophage colony-stimulating factor (M-CSF) on bronchoalveolar macrophages for antihistoplasmal activity
  International Journal of Immunopharmacology, 1995
• Antifungal Activity of Recombinant Human Macrophage Colony-Stimulating Factor in Models of Acute and Chronic Candidiasis in the Rat
  The Journal of Infectious Diseases, 1994
• Efficacy of Unilamellar Liposomal Amphotericin B in Treatment of Pulmonary Aspergillosis in Persistently Granulocytopenic Rabbits: The Potential Role of Bronchoalveolar D-Mannitol and Serum Galactomannan as Markers of Infection
  The Journal of Infectious Diseases, 1994
• Modulation of Host Defenses by Cytokines: Evolving Adjuncts in Prevention and Treatment of Serious Infections in Immunocompromised Hosts
  Clinical Infectious Diseases, 1992
• Patterns of Infection in Patients with Aplastic Anemia and the Emergence of Aspergillus As a Major Cause of Death
  Medicine, 1992
• In vivo effects of macrophage colony-stimulating factor on human monocyte function
  British Journal of Haematology, 1991
• Granulocyte-Macrophage and Macrophage Colony-Stimulating Factors Activate Intramacrophage Killing of Leishmania mexicana amazonensis
  The Journal of Infectious Diseases, 1990
• CT of invasive pulmonary aspergillosis
  American Journal of Roentgenology, 1988
• In Vivo Bronchoalveolar Macrophage Defense Against Rhizopus oryzae and Aspergillus fumigatus
  The Journal of Infectious Diseases, 1984